Chemoinformaics analysis of 15-HYDROXYHENICOSANOIC ACID
| Molecular Weight | 342.564 | nRot | 19 |
| Heavy Atom Molecular Weight | 300.228 | nRig | 27 |
| Exact Molecular Weight | 342.313 | nRing | 0 |
| Solubility: LogS | -4.193 | nHRing | 0 |
| Solubility: LogP | 1.805 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 65.4813 |
| nHD | 2 | BPOL | 43.0027 |
| QED | 0.764 |
| Synth | 6.713 |
| Natural Product Likeliness | 2.783 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.977 |
| Pgp-sub | 0.002 |
| HIA | 0.01 |
| CACO-2 | -4.88 |
| MDCK | 0.0000449 |
| BBB | 0.988 |
| PPB | 0.32986 |
| VDSS | 1.077 |
| FU | 0.580079 |
| CYP1A2-inh | 0.013 |
| CYP1A2-sub | 0.949 |
| CYP2c19-inh | 0.032 |
| CYP2c19-sub | 0.974 |
| CYP2c9-inh | 0.027 |
| CYP2c9-sub | 0.259 |
| CYP2d6-inh | 0.076 |
| CYP2d6-sub | 0.771 |
| CYP3a4-inh | 0.681 |
| CYP3a4-sub | 0.933 |
| CL | 11.862 |
| T12 | 0.036 |
| hERG | 0.112 |
| Ames | 0.613 |
| ROA | 0.736 |
| SkinSen | 0.083 |
| Carcinogencity | 0.701 |
| EI | 0.01 |
| Respiratory | 0.931 |
| NR-Aromatase | 0.859 |
| Antiviral | No |
| Prediction | 0.637929 |